Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study

American Journal on Addictions

Volumn 24, Issue 4, 2015, Pages 329-335

  Woodcock, Eric A ^a,b   Lundahl, Leslie H ^a   Burmeister, Margit ^c   Greenwald, Mark K ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; MU OPIATE RECEPTOR; OPRM1 PROTEIN, HUMAN;

ADULT; ARTICLE; CAUCASIAN; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEROIN DEPENDENCE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPRM1 GENE; OUTCOME ASSESSMENT; PHENOTYPE; PILOT STUDY; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; AFRICAN AMERICAN; ALLELE; DRUG OVERDOSE; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED;

ADULT; AFRICAN AMERICANS; ALLELES; DRUG OVERDOSE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEROIN; HEROIN DEPENDENCE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU; RETROSPECTIVE STUDIES;

EID: 84929047479     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12187     Document Type: Article

References (45)

1. Raynor K, Kong H, Chen Y, et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol. 1994;45:330-334.
2. Lalley PM,. Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol. 2008;164:160-167. DOI: 10.1016/j.resp.2008.02.004
3. Zhang Z, Zhuang J, Zhang C, et al. Activation of opioid μ-receptors in the commissural subdivision of the nucleus tractus solitarius abolishes the ventilatory response to hypoxia in anesthetized rats. Anesthesiology 2011;115:353-363. DOI: 10.1097/ALN.0b013e318224cc1f
4. Bergen AW, Kokoszka J, Peterson R, et al. Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry. 1997;2:490-494. DOI: 10.1038/sj.mp.4000331
5. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998;95:9608-9613.
6. 118G. J Biol Chem. 2005;280:32618-32624. DOI: 10.1074/jbc.M504942200
7. Oertel BG, Doehring A, Roskam B, et al. Genetic-epigenetic interaction modulates μ-opioid receptor regulation. Hum Mol Genet. 2012;21:4751-4760. DOI: 10.1093/hmg/dds314
8. 112G. Addict Biol. 2012a;19:354-361. DOI: 10.1111/j.1369-1600.2012.00484.x
9. Yaksh TL, Yeung JC, Rudy TA,. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 1976;114:83-103.
10. Ingvar M,. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci. 1999;354:1347-1358. DOI: 10.1098/rstb.1999.0483
11. Peyron R, Laurent B, Garcia-Larrea L,. Functional imaging of brain responses to pain. A review and meta-analysis. Clin Neurophysiol. 2000;30:263-288. DOI: 10.1016/S0987-7053(00)00227-6.
12. 118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci USA. 2009;106:10847-10852. DOI: 10.1073/pnas.0901800106
13. 118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006a;105:334-337.
14. 118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006b;50:787-792. DOI: 10.1111/j.1399-6576.2006.01058.x
15. 118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109:520-526. DOI: 10.1097/ALN.0b013e318182af21
16. Tan EC, Lim EC, Teo YY, et al. Ethnicity and OPRM1 variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain. 2009;5:1-8. DOI: 10.1186/1744-8069-5-32.
17. 118G of the mu opioid receptor alters its N-glycosylation and protein stability. Biochem J. 2012;441:379-386. DOI: 10.1042/BJ20111050
18. 118G polymorphism on binding affinity, potency, and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem. 2004;89:553-560. DOI: 10.1111/j.1471-4159.2004.02340.x
19. 118G alters functional properties of the human mu opioid receptor. J Neurochem. 2007;103:77-87. DOI: 10.1111/j.1471-4159.2007.04738.x
20. 118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci USA. 2011;108:9268-9273. DOI: 10.1073/pnas.1018699108
21. 118G) on [11C]carfentanil binding potential: Preliminary findings in human subjects. Int J Neuropsychopharmacol. 2013;16:47-53. DOI: 10.1017/S146114571200017X
22. 118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. Pharmacogenomics Pers Med. 2009;2:9-19.
23. 118G) polymorphism in the μ-opioid receptor gene with substance dependence: A meta analysis. Drug Alcohol Depend. 2006;83:262-268. DOI: 10.1016/j.drugalcdep.2005.11.024
24. Haerian BS, Haerian MS,. OPRM1 rs1799971 polymorphism and opioid dependence: Evidence from a meta-analysis. Pharmacogenomics. 2013;7:813-824. DOI: 10.2217/pgs.13.57
25. Kreek MJ, Nielsen DA, Butelman ER, et al. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience. 2005;8:1450-1457. DOI: 10.1038/nn1583
26. Khokhar JY, Ferguson CS, Zhu AZ, et al. Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu Rev Pharmacol Toxicol. 2010;50:39-61. DOI: 10.1146/annurev.pharmtox.010909.105826
27. Nikolov MA, Beltcheva O, Galabova A, et al. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Drug Alcohol Depend. 2011;117:62-65. DOI: 10.1016/j.drugalcdep.2010.12.026
28. Shi J, Hui L, Xu Y, et al. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Human Mutat. 2002;19:459-460. DOI: 10.1002/humu.9026
29. 118G associated with clinical severity in a drug overdose population. J Med Toxicol. 2013;2:148-154. DOI: 10.1007/s13181-012-0286-3.
30. 112G. Neuroscience. 2012b;205:178-184. DOI: 10.1016/j.neuroscience.2011.12.033
31. Greenwald MK, Hursh SR,. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: Effects of unit price and pre-session drug supply. Drug Alcohol Depend. 2006;85:35-48. DOI: 10.1016/j.drugalcdep.2006.03.007
32. Greenwald MK, Steinmiller CL,. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: Effects of alternative reinforcer magnitude and post-session drug supply. Drug Alcohol Depend. 2009;104:84-93. DOI: 10.1016/j.drugalcdep.2009.04.006
33. Greenwald MK,. Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin-dependent volunteers. Drug Alcohol Depend. 2010;111:64-73. DOI: 10.1016/j.drugalcdep.2010.03.020
34. Greenwald MK, Lundahl LH, Steinmiller CL,. Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals. Psychopharmacology. 2013;225:811-824. DOI: 10.1007/s00213-012-2868-9.
35. Rickham PP,. Human experimentation. Code of ethics of the World Medical Association Declaration of Helsinki. Br Med J. 1964;2:177.
36. Hodgkinson CA, Yuan Q, Xu K, et al. Addictions biology: Haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008;43:505-515. DOI: 10.1093/alcalc/agn032
37. West S.G., Finch J.F., Curran P.J., Structural equation models with nonnormal variables: Problems and remedies, R.H. Hoyle, Structural equation modeling: Concepts, issues, and applications 1995 Newberry Park, CA: Sage Publications; 56-75.
38. Barrio G, De La Fuente L, Lew C, et al. Differences in severity of heroin dependence by route of administration: The importance of length of heroin use. Drug Alcohol Depend. 2001;63:169-177. DOI: 10.1016/S0376-8716(00)00204-0.
39. Gossop M, Griffiths P, Powis B, et al. Severity of dependence and route of administration of heroin, cocaine, and amphetamines. Br J Addict. 1992;87:1527-1536.
40. Smolka M, Schmidt LG,. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999;94:1191-1198. DOI: 10.1046/j.1360-0443
41. Smyth BP, Barry J, Keenan E, et al. Lapse and relapse following treatment of opiate dependence. Ir Med J. 2010;103:176-179.
42. 118G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl). 2006;188:355-363. DOI: 10.1007/s00213-006-0504-2.
43. Munafò MR, Elliot KM, Murphy MF, et al. Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J. 2007;7:353-361. DOI: 10.1038/sj.tpj.6500432
44. Kim SG,. Gender differences in the genetic risk for alcohol dependence-The results of a pharmacogenetic study in Korean alcoholics. Japanese Journal of Alcohol Studies & Drug Dependence 2009;44:680-685.
45. 118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6:159-167. DOI: 10.1016/j.jpain.2004.11.008